Current filters:  
European Union
More than six years after its publication, Regulation (EU) No 536/2014 on clinical trials (the "EU Clinical Trials Regulation")
Arnold & Porter
On 28 September 2021, the European Commission took another step in the implementation of its new pharmaceutical strategy (discussed in more detail in our previous blog posts...
J A Kemp LLP
An orphan drug, or orphan medicinal product, is a medicine that is developed to treat a rare disease, defined as a disease affecting a relatively small number of people as a proportion of the population.
In July we published a briefing regarding the High Court judgement that found in favour of Care UK in relation to the lawfulness of a charge for administration fees.
J A Kemp LLP
You have probably heard talk of bioinformatics - it is an increasingly popular field of research – but do you really know what it is, and how it is affecting research carried out in your area?
J A Kemp LLP
The human body includes tens of trillions of cells, but not all of them are human! This article focuses on the at-least 30 trillion non-human cells that we each carry with us – our microbiome.
Burgess Mee
On 6th September, the Government announced an overhaul of the UK's fertility laws, with plans to extend the storage limit for gametes (sperm and eggs) and embryos from 10 to 55 years for everyone.
How to deal with hype, ethical complexity, and the difficulties of future-proofing
Russell-Cooke Solicitors
Coronary heart disease is the biggest killer of women worldwide yet despite this statistic heart disease and heart attack are still considered to be 'male illnesses'.
Notified body capacity – or a lack thereof – is a topic we love to keep you updated on here at OTP.
Hill Dickinson
Welcome to our September newsletter in which we highlight the legal implications and support we can provide to your business across the full range of Life Sciences practice areas our legal teams cover.
Arnold & Porter
On 16 September, the MHRA published its long awaited consultation on the regulatory framework that will govern medical devices in the UK.
Mills & Reeve
Business leaders know that environmental, social and governance issues are increasingly important – to their customers, their people and their investors.
Withers LLP
Lin Fengru, the 33-year-old co-founder and chief executive of Singapore biotechnology start-up TurtleTree, remembers the doubters in the investor community and their barbs when she started out.
Berg Kaprow Lewis
The Prime Minister has announced the Government's Plan for Health and Social Care. To fund investment in the NHS, there will be a new Health and Social Care Levy.
Winckworth Sherwood
Forecourt convenience stores should prepare for the new Calorie Labelling (Out of Home Sector) (England) Regulations 2021, the Government's latest weapon to address obesity, with statistics showing two-third of adults in the UK are overweight or obese
Mills & Reeve
Sophie Burton-Jones discusses NHSX's Frontline Digitisation programme and the move towards an integrated care approach within the NHS and the foundational role of digital in Integrated Care Systems.
Winckworth Sherwood
Mental incapacity may arise at any age. Commonly it occurs in the elderly, for example, with the onset of dementia or Alzheimer's disease but it may happen at any time,
What should you look for in your #IPstrategy? How can you best adapt this strategy? This will be answered at the luncheon by Dr Markus Zoller (HGF), who will discuss IP strategies with Dr Thomas Tiller (MorphoSys AG)...
The recent publication of the European Commission's proposed Artificial Intelligence Regulation (AIR) has been met with intense interest across the globe, being the first ever legal framework intended ...
FREE News Alerts
Sign Up for our free News Alerts - All the latest articles on your chosen topics condensed into a free bi-weekly email.
Popular Contributors
Upcoming Events
Mondaq Social Media